Global Oncology Biosimilars Market Professional Survey Report 2018

February 2018 | 108 pages | ID: GF222DC24D5EN
QYResearch

Abstracts

This report studies Oncology Biosimilars in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Celltrion Inc.
• Pfizer Inc.
• Biocon
• BIOCAD
• Apotex Inc.
• Dr. Reddy’s Laboratories Ltd.
• Sandoz International GmbH
• Intas Pharmaceuticals Ltd.
• STADA Arzneimittel AG
• Teva Pharmaceutical Industries Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• G-CSF
• Hematopoietic Agents
• Monoclonal Antibodies

By Application, the market can be split into

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Oncology Biosimilars Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF ONCOLOGY BIOSIMILARS

1.1 Definition and Specifications of Oncology Biosimilars
  1.1.1 Definition of Oncology Biosimilars
  1.1.2 Specifications of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
  1.2.1 G-CSF
  1.2.2 Hematopoietic Agents
  1.2.3 Monoclonal Antibodies
1.3 Applications of Oncology Biosimilars
  1.3.1 Retail Pharmacies
  1.3.2 Hospital Pharmacies
  1.3.3 Online Pharmacies
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ONCOLOGY BIOSIMILARS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.3 Manufacturing Process Analysis of Oncology Biosimilars
2.4 Industry Chain Structure of Oncology Biosimilars

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ONCOLOGY BIOSIMILARS

3.1 Capacity and Commercial Production Date of Global Oncology Biosimilars Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Oncology Biosimilars Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Oncology Biosimilars Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Oncology Biosimilars Major Manufacturers in 2017

4 GLOBAL ONCOLOGY BIOSIMILARS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Oncology Biosimilars Capacity and Growth Rate Analysis
  4.2.2 2017 Oncology Biosimilars Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Oncology Biosimilars Sales and Growth Rate Analysis
  4.3.2 2017 Oncology Biosimilars Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Oncology Biosimilars Sales Price
  4.4.2 2017 Oncology Biosimilars Sales Price Analysis (Company Segment)

5 ONCOLOGY BIOSIMILARS REGIONAL MARKET ANALYSIS

5.1 North America Oncology Biosimilars Market Analysis
  5.1.1 North America Oncology Biosimilars Market Overview
  5.1.2 North America 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Oncology Biosimilars Sales Price Analysis
  5.1.4 North America 2017 Oncology Biosimilars Market Share Analysis
5.2 China Oncology Biosimilars Market Analysis
  5.2.1 China Oncology Biosimilars Market Overview
  5.2.2 China 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Oncology Biosimilars Sales Price Analysis
  5.2.4 China 2017 Oncology Biosimilars Market Share Analysis
5.3 Europe Oncology Biosimilars Market Analysis
  5.3.1 Europe Oncology Biosimilars Market Overview
  5.3.2 Europe 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Oncology Biosimilars Sales Price Analysis
  5.3.4 Europe 2017 Oncology Biosimilars Market Share Analysis
5.4 Southeast Asia Oncology Biosimilars Market Analysis
  5.4.1 Southeast Asia Oncology Biosimilars Market Overview
  5.4.2 Southeast Asia 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Oncology Biosimilars Sales Price Analysis
  5.4.4 Southeast Asia 2017 Oncology Biosimilars Market Share Analysis
5.5 Japan Oncology Biosimilars Market Analysis
  5.5.1 Japan Oncology Biosimilars Market Overview
  5.5.2 Japan 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Oncology Biosimilars Sales Price Analysis
  5.5.4 Japan 2017 Oncology Biosimilars Market Share Analysis
5.6 India Oncology Biosimilars Market Analysis
  5.6.1 India Oncology Biosimilars Market Overview
  5.6.2 India 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Oncology Biosimilars Sales Price Analysis
  5.6.4 India 2017 Oncology Biosimilars Market Share Analysis

6 GLOBAL 2013-2018E ONCOLOGY BIOSIMILARS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Oncology Biosimilars Sales by Type
6.2 Different Types of Oncology Biosimilars Product Interview Price Analysis
6.3 Different Types of Oncology Biosimilars Product Driving Factors Analysis
  6.3.1 G-CSF of Oncology Biosimilars Growth Driving Factor Analysis
  6.3.2 Hematopoietic Agents of Oncology Biosimilars Growth Driving Factor Analysis
  6.3.3 Monoclonal Antibodies of Oncology Biosimilars Growth Driving Factor Analysis

7 GLOBAL 2013-2018E ONCOLOGY BIOSIMILARS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Oncology Biosimilars Consumption by Application
7.2 Different Application of Oncology Biosimilars Product Interview Price Analysis
7.3 Different Application of Oncology Biosimilars Product Driving Factors Analysis
  7.3.1 Retail Pharmacies of Oncology Biosimilars Growth Driving Factor Analysis
  7.3.2 Hospital Pharmacies of Oncology Biosimilars Growth Driving Factor Analysis
  7.3.3 Online Pharmacies of Oncology Biosimilars Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ONCOLOGY BIOSIMILARS

8.1 Celltrion Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Celltrion Inc. 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Celltrion Inc. 2017 Oncology Biosimilars Business Region Distribution Analysis
8.2 Pfizer Inc.
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Pfizer Inc. 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Pfizer Inc. 2017 Oncology Biosimilars Business Region Distribution Analysis
8.3 Biocon
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Biocon 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Biocon 2017 Oncology Biosimilars Business Region Distribution Analysis
8.4 BIOCAD
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 BIOCAD 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 BIOCAD 2017 Oncology Biosimilars Business Region Distribution Analysis
8.5 Apotex Inc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Apotex Inc. 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Apotex Inc. 2017 Oncology Biosimilars Business Region Distribution Analysis
8.6 Dr. Reddy’s Laboratories Ltd.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Dr. Reddy’s Laboratories Ltd. 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Dr. Reddy’s Laboratories Ltd. 2017 Oncology Biosimilars Business Region Distribution Analysis
8.7 Sandoz International GmbH
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Sandoz International GmbH 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Sandoz International GmbH 2017 Oncology Biosimilars Business Region Distribution Analysis
8.8 Intas Pharmaceuticals Ltd.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Intas Pharmaceuticals Ltd. 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Intas Pharmaceuticals Ltd. 2017 Oncology Biosimilars Business Region Distribution Analysis
8.9 STADA Arzneimittel AG
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 STADA Arzneimittel AG 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 STADA Arzneimittel AG 2017 Oncology Biosimilars Business Region Distribution Analysis
8.10 Teva Pharmaceutical Industries Ltd.
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Teva Pharmaceutical Industries Ltd. 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Teva Pharmaceutical Industries Ltd. 2017 Oncology Biosimilars Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF ONCOLOGY BIOSIMILARS MARKET

9.1 Global Oncology Biosimilars Market Trend Analysis
  9.1.1 Global 2018-2025 Oncology Biosimilars Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Oncology Biosimilars Sales Price Forecast
9.2 Oncology Biosimilars Regional Market Trend
  9.2.1 North America 2018-2025 Oncology Biosimilars Consumption Forecast
  9.2.2 China 2018-2025 Oncology Biosimilars Consumption Forecast
  9.2.3 Europe 2018-2025 Oncology Biosimilars Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Oncology Biosimilars Consumption Forecast
  9.2.5 Japan 2018-2025 Oncology Biosimilars Consumption Forecast
  9.2.6 India 2018-2025 Oncology Biosimilars Consumption Forecast
9.3 Oncology Biosimilars Market Trend (Product Type)
9.4 Oncology Biosimilars Market Trend (Application)

10 ONCOLOGY BIOSIMILARS MARKETING TYPE ANALYSIS

10.1 Oncology Biosimilars Regional Marketing Type Analysis
10.2 Oncology Biosimilars International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Oncology Biosimilars by Region
10.4 Oncology Biosimilars Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ONCOLOGY BIOSIMILARS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ONCOLOGY BIOSIMILARS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Table Product Specifications of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Global Production Market Share of Oncology Biosimilars by Type in 2017
Figure G-CSF Picture
Table Major Manufacturers of G-CSF
Figure Hematopoietic Agents Picture
Table Major Manufacturers of Hematopoietic Agents
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Table Applications of Oncology Biosimilars
Figure Global Consumption Volume Market Share of Oncology Biosimilars by Application in 2017
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Major Consumers in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Major Consumers in Online Pharmacies
Figure Market Share of Oncology Biosimilars by Regions
Figure North America Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure China Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure Europe Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure Southeast Asia Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure Japan Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure India Oncology Biosimilars Market Size (Million USD) (2013-2025)
Table Oncology Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Oncology Biosimilars in 2017
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Industry Chain Structure of Oncology Biosimilars
Table Capacity and Commercial Production Date of Global Oncology Biosimilars Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Oncology Biosimilars Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Oncology Biosimilars Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Oncology Biosimilars Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Oncology Biosimilars 2013-2018E
Figure Global 2013-2018E Oncology Biosimilars Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Oncology Biosimilars Market Size (Value) and Growth Rate
Table 2013-2018E Global Oncology Biosimilars Capacity and Growth Rate
Table 2017 Global Oncology Biosimilars Capacity (MT) List (Company Segment)
Table 2013-2018E Global Oncology Biosimilars Sales (MT) and Growth Rate
Table 2017 Global Oncology Biosimilars Sales (MT) List (Company Segment)
Table 2013-2018E Global Oncology Biosimilars Sales Price (USD/Kg)
Table 2017 Global Oncology Biosimilars Sales Price (USD/Kg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (MT) of Oncology Biosimilars 2013-2018E
Figure North America 2013-2018E Oncology Biosimilars Sales Price (USD/Kg)
Figure North America 2017 Oncology Biosimilars Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (MT) of Oncology Biosimilars 2013-2018E
Figure China 2013-2018E Oncology Biosimilars Sales Price (USD/Kg)
Figure China 2017 Oncology Biosimilars Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (MT) of Oncology Biosimilars 2013-2018E
Figure Europe 2013-2018E Oncology Biosimilars Sales Price (USD/Kg)
Figure Europe 2017 Oncology Biosimilars Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (MT) of Oncology Biosimilars 2013-2018E
Figure Southeast Asia 2013-2018E Oncology Biosimilars Sales Price (USD/Kg)
Figure Southeast Asia 2017 Oncology Biosimilars Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (MT) of Oncology Biosimilars 2013-2018E
Figure Japan 2013-2018E Oncology Biosimilars Sales Price (USD/Kg)
Figure Japan 2017 Oncology Biosimilars Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (MT) of Oncology Biosimilars 2013-2018E
Figure India 2013-2018E Oncology Biosimilars Sales Price (USD/Kg)
Figure India 2017 Oncology Biosimilars Sales Market Share
Table Global 2013-2018E Oncology Biosimilars Sales (MT) by Type
Table Different Types Oncology Biosimilars Product Interview Price
Table Global 2013-2018E Oncology Biosimilars Sales (MT) by Application
Table Different Application Oncology Biosimilars Product Interview Price
Table Celltrion Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Celltrion Inc. Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Celltrion Inc. Oncology Biosimilars Business Region Distribution
Table Pfizer Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Pfizer Inc. Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Pfizer Inc. Oncology Biosimilars Business Region Distribution
Table Biocon Information List
Table Product A Overview
Table Product B Overview
Table 2015 Biocon Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Biocon Oncology Biosimilars Business Region Distribution
Table BIOCAD Information List
Table Product A Overview
Table Product B Overview
Table 2017 BIOCAD Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 BIOCAD Oncology Biosimilars Business Region Distribution
Table Apotex Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Apotex Inc. Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Apotex Inc. Oncology Biosimilars Business Region Distribution
Table Dr. Reddy’s Laboratories Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Region Distribution
Table Sandoz International GmbH Information List
Table Product A Overview
Table Product B Overview
Table 2017 Sandoz International GmbH Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Sandoz International GmbH Oncology Biosimilars Business Region Distribution
Table Intas Pharmaceuticals Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Intas Pharmaceuticals Ltd. Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Intas Pharmaceuticals Ltd. Oncology Biosimilars Business Region Distribution
Table STADA Arzneimittel AG Information List
Table Product A Overview
Table Product B Overview
Table 2017 STADA Arzneimittel AG Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 STADA Arzneimittel AG Oncology Biosimilars Business Region Distribution
Table Teva Pharmaceutical Industries Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Business Region Distribution
Figure Global 2018-2025 Oncology Biosimilars Market Size (MT) and Growth Rate Forecast
Figure Global 2018-2025 Oncology Biosimilars Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Oncology Biosimilars Sales Price (USD/Kg) Forecast
Figure North America 2018-2025 Oncology Biosimilars Consumption Volume (MT) and Growth Rate Forecast
Figure China 2018-2025 Oncology Biosimilars Consumption Volume (MT) and Growth Rate Forecast
Figure Europe 2018-2025 Oncology Biosimilars Consumption Volume (MT) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Oncology Biosimilars Consumption Volume (MT) and Growth Rate Forecast
Figure Japan 2018-2025 Oncology Biosimilars Consumption Volume (MT) and Growth Rate Forecast
Figure India 2018-2025 Oncology Biosimilars Consumption Volume (MT) and Growth Rate Forecast
Table Global Sales Volume (MT) of Oncology Biosimilars by Type 2018-2025
Table Global Consumption Volume (MT) of Oncology Biosimilars by Application 2018-2025
Table Traders or Distributors with Contact Information of Oncology Biosimilars by Region